Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05881512 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea
A NA study of Obstructive Sleep Apnea and OSA, sponsored by Somnial.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT05881512: Completed NA study of Obstructive Sleep Apnea and OSA, sponsored by Somnial.
NCT05881512 is a NA study of Obstructive Sleep Apnea and OSA that has completed, run by Somnial. The registered enrollment target is 12 participants, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05881512, a NA study of Obstructive Sleep Apnea and OSA, has completed, sponsored by Somnial.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Early feasibility study to estimate the functionality of a novel intervention based on non-invasive transcutaneous electrical stimulation of the hypoglossal nerve to reduce the Apnea Hypopnea Index (AHI).
Primary Outcome
Episodes of apnea and/or hypopnea scored during the course of sleep study
Conditions Studied
Interventions
- DEVICE Transcutaneous Upper Airway Stimulation Device
Study Locations (1)
New York
- United Diagnostics - Commack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2023-02-22 |
| Phase | NA |
What the finished NCT05881512 record still lists
NCT05881512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Upper Airway Stimulation Device is the first listed.
NCT05881512 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05881512 about?
NCT05881512 is a clinical study titled "Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea". Early feasibility study to estimate the functionality of a novel intervention based on non-invasive transcutaneous electrical stimulation of the hypoglossal nerve to reduce the Apnea Hypopnea Index (AHI).
What is the current status of trial NCT05881512?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-09-12. Estimated completion is 2023-02-22.
What conditions does trial NCT05881512 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, OSA.
What interventions are being tested in trial NCT05881512?
The interventions under investigation include: Transcutaneous Upper Airway Stimulation Device (DEVICE).
Who is sponsoring clinical trial NCT05881512?
This trial is sponsored by Somnial, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05881512 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05881512's enrollment target sits among peer trials
12 151st of 155 higher than 5 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI